Ledger.Open graph →

SEC Form D · filed November 21, 2018

Good Therapeutics, Inc

Offering

$18.0M

Sold

$6.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

John Mckearn · Seattle, WADirector Karl Handelsman · Seattle, WADirector John Mulligan · Seattle, WAExec · Director · Promoter Mitchell Mutz · Seattle, WADirector Jixiang An · Athens, GADirector Todd Miller · Broomfield, COExec · Director · Promoter Biao He · Athens, GADirector Piotr Biezychudek · Broomfield, CODirector Vitaly N. Vorobeychik · New York, NYDirector Philip N. Vorobeychik · New York, NYDirector Kirk Brown · Vancouver, WADirector Craig Moody · Vancouver, WAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗